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Foreword
9th International Conference on In Vivo Methods
Monitoring Molecules in Neuroscience, June 16/19, 2001,
University College Dublin, Ireland
Attending the State reception of the 9th International Conference on
In Vivo Methods, Monitoring Molecules in Neuroscience in Dublin
Castle were from the left: Dr. John Lowry, Department of Chemistry,
NUI Maynooth; Dr. Billy O’Connor, Department of Human Anat-
omy and Physiology, University College Dublin (UCD) and chairman
of the local organizing committee; Professor Arvid Carlsson, Depart-
ment of Pharmacology, University of Gothenborg, Sweden, and Nobel
Prize Winner in Physiology and Medicine 2000; Professor Robert
O’Neill, Department of Chemistry, UCD and Dr. John O’Connor,
Department of Human Anatomy and Physiology, UCD.
The 9th International Conference on In Vivo Meth-
ods, Monitoring Molecules in Neuroscience was held in
University College Dublin, Ireland, 16/19th June 2001.
This meeting is one of a series that began in Notting-
ham, UK in 1982 and follows on from previous
successful conferences in Britain (1989), Holland
(1991), France (1994), Spain (1996) and the USA
(1999). Some 55 papers were read and 300 delegates
from over 20 countries presented 150 posters over 3
days. Invited speakers at the conference have submitted
the nine papers in this special issue of the Journal of
Neuroscience Methods.
University College Dublin and The National Uni-
versity of Ireland, Maynooth, jointly organized the
meeting. The topics addressed at this inter-disciplinary
conference included advances in the ability to monitor
various aspects of brain function especially chemical
neurotransmission in the brain of living organisms,
including man. There were special sessions devoted to
on-going technical and methodological advances includ-
ing the development of biosensor technology and
analytical techniques with the ability to detect molecules
in the brain with great sensitivity.
This topic of recent advances in the ability to monitor
chemical and electrical aspects of brain function in the
experimental and clinical neurosciences was well ad-
dressed in the opening plenary session. Mark Wightman
(University of North Carolina, Chapel Hill, USA)
presented a summary on his work with carbon-fiber
microelectrodes and fast-scan voltammetry, now ex-
tended to the awake, freely-moving model. Urban
Ungerstedt (Karolinska Institute, Stockholm, Sweden)
summarized the recent status of intracerebral micro-
dialysis in humans following stroke and traumatic brain
injury, whereas Tony Grace discussed electrophysiolo-
gical approaches to analyzing systems interactions on a
synaptic and network level. In fact, most of the
presentations at the meeting were focused on various
aspects of microdialysis sampling or electrochemical
sensing devices. In other approaches to neurochemical
monitoring, Vickie Chapman (School of Biomedical
Science, Nottingham, UK) described how fMRI in
small animals is a novel approach in neuropharmacol-
ogy while Martyn Boutelle (Kings College, London,
UK) described recent advances in on-line electrochemi-
cal detection systems for clinical and pre-clinical neuro-
chemical analysis.
The second plenary session addressed the issue of
synaptic and non-synaptic transmission and was in-
itiated by Manuel Mas (University of La Laguna,
Tenerife, Spain) who described changes in nitric oxide
levels in the corpus cavernosa during penile erection.
The case for volume transmission for noradrenaline in
the locus coerulus was put forward by Jonathan
Stamford (Royal Hospital, London UK) whereas M.
Benoit-Marand (University of Bordeaux, France) de-
scribed the kinetics and geometry of autoregulation of
striatal dopamine release. Nicolas Hussy (CNRS, Mon-
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tpellier, France) gave a very interesting talk on evidence
for taurine and glycine receptors as mediators of glia-to-
neuron transmission in the hypothalamus.
The third plenary session addressed issues relating to
neurotransmission and behaviour. Matthijs Feenstra
(Netherlands Institute for Brian Research, Amsterdam,
The Netherlands) described how prefrontal dopamine
and noradrenaline release may be related to the rele-
vance of a task performed during classical conditioning
and operant behaviour. In a similar vein, Gaetano Di
Chiara (University of Calgiari, Sardinia, Italy) provided
strong evidence for a role for dopamine release in the
prefrontal cortex and the core and shell of the accum-
bens in meditating the psychomotor aspects of addic-
tion. Holger Stark (Leibnitz institute for Neurobiology,
Magdeburg, Germany) also described how an increase
in prefrontal dopamine release in gerbils might underlie
the acquisition of avoidance strategy in the shuttle box.
John P. Bruno (Ohio State University, USA) demon-
strated how the use of multiple dialysis probes can
reveal a distributed neural system underlying attentional
processing in the rat, whereas Robert Strecker (Harvard
Medical School, USA) described how neuromodulators
such as adenosine play a key role in the sleep-wake
cycle.
Six parallel symposia addressed microdialysis sam-
pling issues, in-vivo voltammetry and developments in
biosensor technology. Ken Perry (Eli Lilly, Indianapo-
lis, USA) initiated the microdialysis session with a
description of procedural issues in HPLC analysis.
Yvette Michotte (Vrjie University of Brussels, Belgium)
gave a description of quantitative microdialysis in PK/
PD studies while Kelly Drew (Institute of Arctic
Biology, Fairbanks, USA) described the nature of
striatal glutamate levels and tissue trauma in the
hibernating arctic ground squirrel. Elizabeth A. Pehek
(Case Western University, USA) provided strong evi-
dence for a heteroreceptor regulation of the rat meso-
cortical system by cortical serotonin 5-HT2A receptors,
whereas Phillip Thomas (University College Dublin,
Ireland) described how intracerebral microdialysis in
man is applied to study the temporal neocortex and
hippocampus during epilepsy neurosurgery.
David Sulzer (Columbia University, USA) initiated
the session on recent progress in voltammetry and
biosensor technologies by describing how dopamine
release can be monitored in the cellular microenviron-
ment in vivo and in vitro, whereas John Lowry
(National University of Ireland, Maynooth) demon-
strated recent developments in biosensor technology for
in-vivo monitoring of brain energy metabolism. Andrew
Ewing (Pennsylvania State University, USA) described
the electrochemical and separations-based sensing of
neurotransmitter dynamics and storage at cells and
varicosities in culture, whereas voltammetric detection
of rat brain glucose and lactate was discussed by
Raymond Cespuglio (Claude Bernard University,
Lyon, France).
The session on monoamines, acetylcholine and second
messengers was initiated by Umberto Spampinato
(University of Bordeaux, France) who described the
role of the serotonergic (5-HT) system in the control of
nigrostriatal and mesolimbic DA neurons. This was
followed by a talk by Jan Kehr (Karolinska Institute,
Stockholm, Sweden) on hippocampal cholinergic/5-HT
interactions and the modulatory role of the neuropep-
tide galanin and their possible implications in Alzhei-
mer’s disease and depression. Atsushi Yamatodani
(Osaka University, Japan) provided evidence for a
neuronal pool of extracellular histamine in the hypotha-
lamus, whereas using dual probe microdialysis in six-
hydroxydopamine treated rats, Michele Morari (Uni-
versity of Ferrara, Italy) investigated the possible
mechanisms by which striatal dopamine and glutamate
regulate striatonigral glutamate release. John O’Connor
(University College Dublin, Ireland) presented data on
the relationship between LTP and intracellular MAP
kinases in CA1 hippocampal neurons and showed that
pro-inflammatory cytokines have marked effects on
synaptic transmission.
The session on amino acids and neuropeptides
attracted much interest. Ben Westerink (University
Centre for Pharmacy, Groningen, The Netherlands)
discussed the controversial issue of the neuronal origin
of extracellular amino acid levels. In her talk provoca-
tively entitled The theology of amino acid microdialysis:
the mystery of origin and meaning Kristen Keeffe
(University of Utah, USA) explained the key role of
reuptake mechanisms in maintaining extracellular ami-
no acid levels, whereas factors influencing amino acid
transporters was discussed by Peter Kalivas (Medical
University of South Carolina, USA). By combining
microdialysis and immunocytochemistry, Charles Me-
shul (Oregon Health Sciences University, USA) de-
scribed how loss of dopamine affects striatal
glutamatergic function.
In the session on novel and combined approaches
Trevor Sharp (University of Oxford, UK) described how
integrated studies employing electrophysiology, micro-
dialysis and in situ hybridization may give a better
perspective on neuronal function. Michael G. Kaplitt
(Cornell University, USA) described how microdialysis
and deep brain stimulation can be combined in human
Parkinson’s disease patients. Raul Gaitainidov (Duke
University, USA) showed how the combination of in
vivo microdialysis and voltammetry can reveal altera-
tions in dopamine transmission in mice with genetic
deletions of both the dopamine and norepinephrine
transporters. The use of intracerebral microdialysis in
drug-induced and kindling models of epilepsy was
presented by Rob Berman (University of California,
Davis, USA) whereas Larry Parsons (Scripps Research
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Institute, USA) argued the ‘pros and cons’ of the
capillary electrophoresis/mass spectroscopy approach
compared with the HPLC/mass spectroscopy ap-
proach, while giving an overview of recent trends in
peptide separation and detection.
In light of the fact that many pharmaceutical compa-
nies active in the CNS therapeutic area utilize micro-
dialysis as a research tool to obtain neurochemical
correlates to various behavioural tests or pharmacolo-
gical treatments, a special session was devoted to drug
action and development. The benefits of microdialysis in
the process of drug discovery were discussed by Hans
Rollema of Pfizer, Groton, USA (depression, schizo-
phrenia) and Peter Hertel of Lundbeck, Copenhagen,
Denmark (schizophrenia, relevance to behavioural mod-
els). Francesco Crespi (Glaxo Wellcome, Verona, Italy)
described concomitant in-vivo voltammetric and elec-
trophysiological studies in cortical and subcortical brain
regions, whereas Sophie Sarre (Vrjie University of
Brussels, Belgium) described the nerve circuitry of the
basal ganglia as studied with microdialysis.
On the second evening of the conference a state
reception was held in Dublin Castle and this was
followed on the final evening by a banquet to honor
the award of the Nobel Prize in Physiology and
Medicine (2000) to Professor Arvid Carlsson (University
of Gothenborg, Sweden). Professor Carlsson was invited
to cut a special commemorative cake baked in the shape
of a dopamine molecule (the discovery of which earned
him the Nobel Prize) and he also gave a keynote address
on the research personalities he encountered on the road
to the Nobel Prize. To commemorate his achievement
Dr Billy O’Connor presented Professor Carlsson with a
specially engraved Irish millennium silver plate on
behalf of the local and international organizing com-
mittees.
As has been the tradition for these meetings, the
organizers have, under the auspices of the host Uni-
versity (UCD), published a book in the Series: ‘Mon-
itoring Molecules in Neuroscience ’ (ISBN number 1-
902277-47-3). This book contains the 205 short papers
submitted by the oral and poster presenters.
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